Curapath is a CDMO with expertise in developing novel drug delivery systems (DDS). What sets us apart is our analytical expertise in the formulation and manufacturing of Lipid nanoparticles (LNP) and Polymer nanoparticles (PNP). When you start working with Curapath, we can support your entire therapeutic journey from development to IND. Curapath supports GMP manufacturing of Drug Substance and Drug Product for clinical trial material. We provided unmatched technical support and analytical expertise in the custom design, development, and end-to-end GMP manufacturing of polymer and lipid-based drug delivery systems to support cell therapy, gene therapy, and vaccine delivery. For over a decade, Curapath has supported drug innovators in developing stealth shielding polymers (polyaminoacids), functional polymer & lipid excipients, linkers for bioconjugation, and API polymers used for therapeutics. Our history of success makes Curapath the right partner to drive your therapeutic development. We deliver consultative hands-on guidance from preclinical development through commercial-scale GMP manufacturing. Curapath is a knowledgeable partner you can trust to move fast, manufacture smart, and provide support through your drug development journey, accelerating your speed to the clinic. We help our partners solve even the most complex drug delivery challenges.
View Top Employees from CurapathWebsite | https://curapath.com/ |
Revenue | $2.6 million |
Employees | 90 (68 on RocketReach) |
Founded | 2013 |
Address | Av. Eduardo Primo Yúfera 3, Valencia, Valencia 46012, ES |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Industry | Pharmaceutical Manufacturing |
Looking for a particular Curapath employee's phone or email?
The Curapath annual revenue was $2.6 million in 2024.
Nicolas Serra is the CFO of Curapath.
68 people are employed at Curapath.
Curapath is based in Valencia, Valencia.